LINO LAMB: Open Payments
NPI 1588212575 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,766 in 139 payments from 17 companies in 2025. Trend: 2023 $160 · 2024 $89 · 2025 $2,766
Food & beverage: $2,681Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $678 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 31 | $531 |
| Janssen Biotech, Inc. | 20 | $487 |
| Ipsen Biopharmaceuticals, Inc | 8 | $250 |
| Aimmune Therapeutics, Inc. | 11 | $242 |
| Madrigal Pharmaceuticals | 1 | $150 |
| Regeneron Healthcare Solutions, Inc. | 5 | $96 |
| Lilly USA, LLC | 4 | $72 |
| Intercept Pharmaceuticals, Inc. | 4 | $61 |
| Ardelyx, Inc. | 2 | $51 |
Products named: TREMFYA, XIFAXAN, IQIRVO, ZENPEP, RINVOQ, LINZESS, RELISTOR, SKYRIZI.
Industry payments across AR — which companies pay providers there.
